Merck KGaA (MRK) - Total Liabilities
Based on the latest financial reports, Merck KGaA (MRK) has total liabilities worth €21.93 Billion EUR (≈ $25.63 Billion USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Merck KGaA (MRK) cash flow conversion to assess how effectively this company generates cash.
Merck KGaA - Total Liabilities Trend (2002–2024)
This chart illustrates how Merck KGaA's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Merck KGaA to evaluate the company's liquid asset resilience ratio.
Merck KGaA Competitors by Total Liabilities
The table below lists competitors of Merck KGaA ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hologic Inc
NASDAQ:HOLX
|
USA | $3.94 Billion |
|
BE SEMICON.INDS NY EO091
F:BSIA
|
Germany | €697.35 Million |
|
KGHM Polska Miedz SA
WAR:KGH
|
Poland | zł22.73 Billion |
|
Brookfield Infrastructure Partners LP
NYSE:BIP
|
USA | $92.61 Billion |
|
Rede D'Or São Luiz S.A.
SA:RDOR3
|
Brazil | R$81.23 Billion |
|
Affirm Holdings Inc
NASDAQ:AFRM
|
USA | $9.41 Billion |
Liability Composition Analysis (2002–2024)
This chart breaks down Merck KGaA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Merck KGaA market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.49 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.43 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Merck KGaA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Merck KGaA (2002–2024)
The table below shows the annual total liabilities of Merck KGaA from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €21.58 Billion ≈ $25.23 Billion |
-0.74% |
| 2023-12-31 | €21.74 Billion ≈ $25.42 Billion |
-3.47% |
| 2022-12-31 | €22.52 Billion ≈ $26.33 Billion |
-5.95% |
| 2021-12-31 | €23.95 Billion ≈ $28.00 Billion |
-3.36% |
| 2020-12-31 | €24.78 Billion ≈ $28.97 Billion |
-4.32% |
| 2019-12-31 | €25.90 Billion ≈ $30.28 Billion |
+31.76% |
| 2018-12-31 | €19.66 Billion ≈ $22.98 Billion |
-8.81% |
| 2017-12-31 | €21.55 Billion ≈ $25.20 Billion |
-10.93% |
| 2016-12-31 | €24.20 Billion ≈ $28.29 Billion |
-3.78% |
| 2015-12-31 | €25.15 Billion ≈ $29.41 Billion |
+77.01% |
| 2014-12-31 | €14.21 Billion ≈ $16.61 Billion |
+45.74% |
| 2013-12-31 | €9.75 Billion ≈ $11.40 Billion |
-13.17% |
| 2012-12-31 | €11.23 Billion ≈ $13.13 Billion |
-3.42% |
| 2011-12-31 | €11.63 Billion ≈ $13.59 Billion |
-3.24% |
| 2010-12-31 | €12.02 Billion ≈ $14.05 Billion |
+66.91% |
| 2009-12-31 | €7.20 Billion ≈ $8.42 Billion |
+19.50% |
| 2008-12-31 | €6.02 Billion ≈ $7.04 Billion |
-3.38% |
| 2007-12-31 | €6.23 Billion ≈ $7.29 Billion |
+45.16% |
| 2006-12-31 | €4.30 Billion ≈ $5.02 Billion |
+8.69% |
| 2005-12-31 | €3.95 Billion ≈ $4.62 Billion |
+39.77% |
| 2004-12-31 | €2.83 Billion ≈ $3.31 Billion |
-38.79% |
| 2003-12-31 | €4.62 Billion ≈ $5.40 Billion |
-15.36% |
| 2002-12-31 | €5.46 Billion ≈ $6.38 Billion |
-- |
About Merck KGaA
Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more